Literature DB >> 10647696

Quality of nucleic acids extracted from fresh prostatic tissue obtained from TURP procedures.

S H Margan1, D J Handelsman, S Mann, P Russell, J Rogers, M H Khadra, Q Dong.   

Abstract

PURPOSE: The molecular genetic study of benign prostatic hyperplasia (BPH) requires high quality nucleic acids from BPH tissue. It has been generally assumed, but not experimentally proven, that the diathermy used in trans-urethral resection of the prostate (TURP) damages nucleic acids.
MATERIALS AND METHODS: Total RNA, polyA+ RNA and genomic DNA isolated from fresh tissue obtained from TURP procedures were compared with those isolated from tissue obtained from open prostatectomy.
RESULTS: On a formaldehyde agarose gel, there was an increase in low molecular weight RNA in the TURP derived samples, in comparison to that in the open prostatectomy derived samples. The 28S and 18S rRNA were present in all TURP specimens and although the two bands were reduced in some samples, there were samples in which the 2 bands were indistinguishable from the open prostatectomy derived samples. Low molecular weight fragments seen in total RNA were reduced greatly in polyA+ RNA and the difference in polyA+ RNA between the TURP and open prostatectomy derived samples was significantly diminished. RT-PCR of two ubiquitously expressed gene transcripts (Galpha11, 256 bp and HPRT, 847 bp) yielded products of similar size and intensity between TURP and open prostatectomy derived samples. Genomic DNA obtained from TURP derived specimens showed no difference in size or enzyme digestibility in comparison to that from open prostatectomy.
CONCLUSIONS: Nucleic acids extracted from fresh prostatic tissue derived from TURP procedures can be used as readily as any other fresh tissue for RT-PCR based molecular genetic studies, although polyA+ RNA isolation is recommended if degradation-free RNA is required.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10647696

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

1.  Caspase-1 and -3 mRNAs are differentially upregulated in motor neurons and glial cells in mutant SOD1 transgenic mouse spinal cord: a study using laser microdissection and real-time RT-PCR.

Authors:  Yoshio Ando; Yideng Liang; Shinsuke Ishigaki; Jun-ichi Niwa; Yuemei Jiang; Yasushi Kobayashi; Masahiko Yamamoto; Manabu Doyu; Gen Sobue
Journal:  Neurochem Res       Date:  2003-06       Impact factor: 3.996

2.  Muscarinic receptor subtype mRNA expression in the human prostate: association with age, pathological diagnosis, prostate size, or potentially interfering medications?

Authors:  Lambertus P W Witte; Christine A Teitsma; Jean J M C H de la Rosette; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-11-06       Impact factor: 3.000

3.  Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces.

Authors:  Sandrine Imbeaud; Esther Graudens; Virginie Boulanger; Xavier Barlet; Patrick Zaborski; Eric Eveno; Odilo Mueller; Andreas Schroeder; Charles Auffray
Journal:  Nucleic Acids Res       Date:  2005-03-30       Impact factor: 16.971

Review 4.  Methodological aspects of the molecular and histological study of prostate cancer: focus on PTEN.

Authors:  Aitziber Ugalde-Olano; Ainara Egia; Sonia Fernández-Ruiz; Ana Loizaga-Iriarte; Patricia Zuñiga-García; Stephane Garcia; Félix Royo; Isabel Lacasa-Viscasillas; Erika Castro; Ana R Cortazar; Amaia Zabala-Letona; Natalia Martín-Martín; Amaia Arruabarrena-Aristorena; Verónica Torrano-Moya; Lorea Valcárcel-Jiménez; Pilar Sánchez-Mosquera; Alfredo Caro-Maldonado; Jorge González-Tampan; Guido Cachi-Fuentes; Elena Bilbao; Rocío Montero; Sara Fernández; Edurne Arrieta; Kerman Zorroza; Mireia Castillo-Martín; Violeta Serra; Eider Salazar; Nuria Macías-Cámara; Jose Tabernero; Jose Baselga; Carlos Cordón-Cardo; Ana M Aransay; Amaia Del Villar; Juan L Iovanna; Juan M Falcón-Pérez; Miguel Unda; Roberto Bilbao; Arkaitz Carracedo
Journal:  Methods       Date:  2015-02-16       Impact factor: 3.608

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.